Status:
COMPLETED
Hypothermia Risk Prediction Combined With Active Insulation Management in Geriatric Surgery
Lead Sponsor:
First Affiliated Hospital of Chongqing Medical University
Conditions:
Hypothermia; Anesthesia
Body Temperature Changes
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
To evaluate the effectiveness and safety of hypothermia risk prediction combined with active warming management to reduce intraoperative hypothermia in elderly patients undergoing elective general ane...
Eligibility Criteria
Inclusion
- Age ≥ 60 years, male or female.
- Elective general anesthesia for surgery.
- Operative time ≥ 30 min.
- Preoperative body temperature within the normal range.
- Normal preoperative bleeding and clotting time.
Exclusion
- Mental illness.
- High or low basal hypothermia with high or low metabolic disease (patients with central hyperthermia include those with cerebrovascular vascular disease, traumatic brain injury and brain surgery, epilepsy, central hyperthermia due to acute hydrocephalus; thermoregulatory abnormalities including malignant hyperthermia (MHS), neuroleptic malignant syndrome and those with definite evidence of diagnosed hypo- or hyperthyroidism and current abnormal thyroid function).
- Impaired skin insulation barriers such as large skin burns.
- Infectious fever.
- Other causes of body temperature above 38.5 °C three days before surgery.
- Other persons deemed unsuitable by the investigator to participate in the clinical trial.
- Refusal to sign the informed consent form.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
1360 Patients enrolled
Trial Details
Trial ID
NCT05430997
Start Date
June 1 2022
End Date
August 1 2023
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Chongqing Medical University
Chongqing, China, 400010